Diabetic endothelial dysfunction: Role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation

Francisco Soriano, László Virág, Csaba Szabo

Research output: Contribution to journalArticle

122 Citations (Scopus)

Abstract

Peroxynitrite and hydroxyl radicals are potent initiators of DNA single-strand breakage, which is an obligatory stimulus for the activation of the nuclear enzyme poly(ADP ribose) polymerase (PARP). In response to high glucose incubation medium in vitro, or diabetes and hyperglycemia in vivo, reactive nitrogen and oxygen species generation occurs. These reactive species trigger DNA single-strand breakage, which induces rapid activation of PARR PARP in turn depletes the intracellular concentration of its substrate, NAD+, slowing the rate of glycolysis, electron transport, and ATP formation. This process results in acute endothelial dysfunction in diabetic blood vessels. Accordingly, inhibitors of PARP protect against endothelial injury under these conditions. In addition to the direct cytotoxic pathway regulated by DNA injury and PARP activation, PARP also appears to modulate the course of inflammation by regulating the activation of nuclear factor κB, and the expression of a number of genes, including the gene for intercellular adhesion molecule 1 and the inducible nitric oxide synthase. The research into the role of PARP in diabetic vascular injury is now supported by novel tools, such as new classes of potent inhibitors of PARP and genetically engineered animals lacking the gene for PARR Pharmacological inhibition of PARP emerges as a potential approach for the experimental therapy of diabetic vascular dysfunction.

Original languageEnglish (US)
Pages (from-to)437-448
Number of pages12
JournalJournal of Molecular Medicine
Volume79
Issue number8
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Reactive Nitrogen Species
Poly(ADP-ribose) Polymerases
Reactive Oxygen Species
Blood Vessels
Genes
Investigational Therapies
Genetically Modified Animals
Peroxynitrous Acid
Enzyme Activation
Vascular System Injuries
DNA
Nitric Oxide Synthase Type II
Glycolysis
Intercellular Adhesion Molecule-1
Electron Transport
Hyperglycemia
Hydroxyl Radical
NAD
DNA Damage
Adenosine Triphosphate

Keywords

  • Cytokine
  • Diabetes vascular
  • Free radicals
  • Nitric oxide
  • Oxidants

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Diabetic endothelial dysfunction : Role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation. / Soriano, Francisco; Virág, László; Szabo, Csaba.

In: Journal of Molecular Medicine, Vol. 79, No. 8, 2001, p. 437-448.

Research output: Contribution to journalArticle

@article{406c8639e1464bddb59b8b86c63d505a,
title = "Diabetic endothelial dysfunction: Role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation",
abstract = "Peroxynitrite and hydroxyl radicals are potent initiators of DNA single-strand breakage, which is an obligatory stimulus for the activation of the nuclear enzyme poly(ADP ribose) polymerase (PARP). In response to high glucose incubation medium in vitro, or diabetes and hyperglycemia in vivo, reactive nitrogen and oxygen species generation occurs. These reactive species trigger DNA single-strand breakage, which induces rapid activation of PARR PARP in turn depletes the intracellular concentration of its substrate, NAD+, slowing the rate of glycolysis, electron transport, and ATP formation. This process results in acute endothelial dysfunction in diabetic blood vessels. Accordingly, inhibitors of PARP protect against endothelial injury under these conditions. In addition to the direct cytotoxic pathway regulated by DNA injury and PARP activation, PARP also appears to modulate the course of inflammation by regulating the activation of nuclear factor κB, and the expression of a number of genes, including the gene for intercellular adhesion molecule 1 and the inducible nitric oxide synthase. The research into the role of PARP in diabetic vascular injury is now supported by novel tools, such as new classes of potent inhibitors of PARP and genetically engineered animals lacking the gene for PARR Pharmacological inhibition of PARP emerges as a potential approach for the experimental therapy of diabetic vascular dysfunction.",
keywords = "Cytokine, Diabetes vascular, Free radicals, Nitric oxide, Oxidants",
author = "Francisco Soriano and L{\'a}szl{\'o} Vir{\'a}g and Csaba Szabo",
year = "2001",
doi = "10.1007/s001090100236",
language = "English (US)",
volume = "79",
pages = "437--448",
journal = "Journal of Molecular Medicine",
issn = "0946-2716",
publisher = "Springer Verlag",
number = "8",

}

TY - JOUR

T1 - Diabetic endothelial dysfunction

T2 - Role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation

AU - Soriano, Francisco

AU - Virág, László

AU - Szabo, Csaba

PY - 2001

Y1 - 2001

N2 - Peroxynitrite and hydroxyl radicals are potent initiators of DNA single-strand breakage, which is an obligatory stimulus for the activation of the nuclear enzyme poly(ADP ribose) polymerase (PARP). In response to high glucose incubation medium in vitro, or diabetes and hyperglycemia in vivo, reactive nitrogen and oxygen species generation occurs. These reactive species trigger DNA single-strand breakage, which induces rapid activation of PARR PARP in turn depletes the intracellular concentration of its substrate, NAD+, slowing the rate of glycolysis, electron transport, and ATP formation. This process results in acute endothelial dysfunction in diabetic blood vessels. Accordingly, inhibitors of PARP protect against endothelial injury under these conditions. In addition to the direct cytotoxic pathway regulated by DNA injury and PARP activation, PARP also appears to modulate the course of inflammation by regulating the activation of nuclear factor κB, and the expression of a number of genes, including the gene for intercellular adhesion molecule 1 and the inducible nitric oxide synthase. The research into the role of PARP in diabetic vascular injury is now supported by novel tools, such as new classes of potent inhibitors of PARP and genetically engineered animals lacking the gene for PARR Pharmacological inhibition of PARP emerges as a potential approach for the experimental therapy of diabetic vascular dysfunction.

AB - Peroxynitrite and hydroxyl radicals are potent initiators of DNA single-strand breakage, which is an obligatory stimulus for the activation of the nuclear enzyme poly(ADP ribose) polymerase (PARP). In response to high glucose incubation medium in vitro, or diabetes and hyperglycemia in vivo, reactive nitrogen and oxygen species generation occurs. These reactive species trigger DNA single-strand breakage, which induces rapid activation of PARR PARP in turn depletes the intracellular concentration of its substrate, NAD+, slowing the rate of glycolysis, electron transport, and ATP formation. This process results in acute endothelial dysfunction in diabetic blood vessels. Accordingly, inhibitors of PARP protect against endothelial injury under these conditions. In addition to the direct cytotoxic pathway regulated by DNA injury and PARP activation, PARP also appears to modulate the course of inflammation by regulating the activation of nuclear factor κB, and the expression of a number of genes, including the gene for intercellular adhesion molecule 1 and the inducible nitric oxide synthase. The research into the role of PARP in diabetic vascular injury is now supported by novel tools, such as new classes of potent inhibitors of PARP and genetically engineered animals lacking the gene for PARR Pharmacological inhibition of PARP emerges as a potential approach for the experimental therapy of diabetic vascular dysfunction.

KW - Cytokine

KW - Diabetes vascular

KW - Free radicals

KW - Nitric oxide

KW - Oxidants

UR - http://www.scopus.com/inward/record.url?scp=0034890040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034890040&partnerID=8YFLogxK

U2 - 10.1007/s001090100236

DO - 10.1007/s001090100236

M3 - Article

C2 - 11511974

AN - SCOPUS:0034890040

VL - 79

SP - 437

EP - 448

JO - Journal of Molecular Medicine

JF - Journal of Molecular Medicine

SN - 0946-2716

IS - 8

ER -